IBDEI096 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12118,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,12118,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,12118,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,12119,0)
 ;;=V15.3^^74^685^52
 ;;^UTILITY(U,$J,358.3,12119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12119,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,12119,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,12119,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,12120,0)
 ;;=V10.61^^74^685^26
 ;;^UTILITY(U,$J,358.3,12120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12120,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,12120,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,12120,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,12121,0)
 ;;=V12.03^^74^685^27
 ;;^UTILITY(U,$J,358.3,12121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12121,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,12121,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,12121,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,12122,0)
 ;;=V10.82^^74^685^28
 ;;^UTILITY(U,$J,358.3,12122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12122,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,12122,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,12122,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,12123,0)
 ;;=V10.62^^74^685^30
 ;;^UTILITY(U,$J,358.3,12123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12123,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,12123,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,12123,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,12124,0)
 ;;=V10.63^^74^685^29
 ;;^UTILITY(U,$J,358.3,12124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12124,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,12124,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,12124,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,12125,0)
 ;;=V11.2^^74^685^24
 ;;^UTILITY(U,$J,358.3,12125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12125,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,12125,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,12125,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,12126,0)
 ;;=V15.81^^74^685^40
 ;;^UTILITY(U,$J,358.3,12126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12126,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,12126,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,12126,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,12127,0)
 ;;=V10.43^^74^685^31
 ;;^UTILITY(U,$J,358.3,12127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12127,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,12127,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,12127,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,12128,0)
 ;;=V12.71^^74^685^32
 ;;^UTILITY(U,$J,358.3,12128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12128,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,12128,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,12128,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,12129,0)
 ;;=V10.46^^74^685^33
 ;;^UTILITY(U,$J,358.3,12129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12129,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,12129,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,12129,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,12130,0)
 ;;=V11.0^^74^685^34
 ;;^UTILITY(U,$J,358.3,12130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12130,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,12130,1,5,0)
 ;;=5^Hx of Schizophrenia
 ;;^UTILITY(U,$J,358.3,12130,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,12131,0)
 ;;=V10.83^^74^685^35
 ;;^UTILITY(U,$J,358.3,12131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12131,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,12131,1,5,0)
 ;;=5^Hx of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,12131,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,12132,0)
 ;;=V15.1^^74^685^36
 ;;^UTILITY(U,$J,358.3,12132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12132,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,12132,1,5,0)
 ;;=5^Hx of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,12132,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,12133,0)
 ;;=V15.82^^74^685^38
 ;;^UTILITY(U,$J,358.3,12133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12133,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,12133,1,5,0)
 ;;=5^Hx of Tobacco Use (not current)
 ;;^UTILITY(U,$J,358.3,12133,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,12134,0)
 ;;=V12.01^^74^685^37
 ;;^UTILITY(U,$J,358.3,12134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12134,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,12134,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,12134,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,12135,0)
 ;;=V13.01^^74^685^25
 ;;^UTILITY(U,$J,358.3,12135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12135,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,12135,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,12135,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,12136,0)
 ;;=V12.51^^74^685^39
 ;;^UTILITY(U,$J,358.3,12136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12136,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,12136,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,12136,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,12137,0)
 ;;=V17.89^^74^685^1
 ;;^UTILITY(U,$J,358.3,12137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12137,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,12137,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,12137,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,12138,0)
 ;;=V12.54^^74^685^55
 ;;^UTILITY(U,$J,358.3,12138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12138,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,12138,1,5,0)
 ;;=5^Personal h/o TIA
 ;;^UTILITY(U,$J,358.3,12138,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,12139,0)
 ;;=V12.54^^74^685^54
 ;;^UTILITY(U,$J,358.3,12139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12139,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,12139,1,5,0)
 ;;=5^Personal h/o Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,12139,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,12140,0)
 ;;=V15.88^^74^685^50
 ;;^UTILITY(U,$J,358.3,12140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12140,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,12140,1,5,0)
 ;;=5^Personal h/o Fall(s)
 ;;^UTILITY(U,$J,358.3,12140,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,12141,0)
 ;;=V13.59^^74^685^23
 ;;^UTILITY(U,$J,358.3,12141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12141,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,12141,1,5,0)
 ;;=5^Hx Musculoskletl Dis
 ;;^UTILITY(U,$J,358.3,12141,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,12142,0)
 ;;=V15.52^^74^685^56
 ;;^UTILITY(U,$J,358.3,12142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12142,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,12142,1,5,0)
 ;;=5^Personal h/o Traum Brain Inj
 ;;^UTILITY(U,$J,358.3,12142,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,12143,0)
 ;;=V70.0^^74^686^1
 ;;^UTILITY(U,$J,358.3,12143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12143,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,12143,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,12143,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,12144,0)
 ;;=V77.91^^74^686^2
 ;;^UTILITY(U,$J,358.3,12144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12144,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,12144,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,12144,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,12145,0)
 ;;=V76.44^^74^686^3
 ;;^UTILITY(U,$J,358.3,12145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12145,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,12145,1,5,0)
 ;;=5^Screen for Prostate CA
 ;;^UTILITY(U,$J,358.3,12145,2)
 ;;=Screen for Prostate CA^321548
 ;;^UTILITY(U,$J,358.3,12146,0)
 ;;=V74.5^^74^686^5
 ;;^UTILITY(U,$J,358.3,12146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12146,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,12146,1,5,0)
 ;;=5^Screening for STD's
 ;;^UTILITY(U,$J,358.3,12146,2)
 ;;=Screening for STD's^295637
 ;;^UTILITY(U,$J,358.3,12147,0)
 ;;=V73.89^^74^686^4
 ;;^UTILITY(U,$J,358.3,12147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12147,1,4,0)
 ;;=4^V73.89
 ;;^UTILITY(U,$J,358.3,12147,1,5,0)
 ;;=5^Screening for HIV
 ;;^UTILITY(U,$J,358.3,12147,2)
 ;;=^295833
 ;;^UTILITY(U,$J,358.3,12148,0)
 ;;=919.1^^74^687^1
 ;;^UTILITY(U,$J,358.3,12148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12148,1,4,0)
 ;;=4^919.1
 ;;^UTILITY(U,$J,358.3,12148,1,5,0)
 ;;=5^Abrasion, Infected
 ;;^UTILITY(U,$J,358.3,12148,2)
 ;;=^275358
 ;;^UTILITY(U,$J,358.3,12149,0)
 ;;=919.0^^74^687^2
 ;;^UTILITY(U,$J,358.3,12149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12149,1,4,0)
 ;;=4^919.0
 ;;^UTILITY(U,$J,358.3,12149,1,5,0)
 ;;=5^Abrasion, Not Infected
 ;;^UTILITY(U,$J,358.3,12149,2)
 ;;=^1305
 ;;^UTILITY(U,$J,358.3,12150,0)
 ;;=924.9^^74^687^3
 ;;^UTILITY(U,$J,358.3,12150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12150,1,4,0)
 ;;=4^924.9
 ;;^UTILITY(U,$J,358.3,12150,1,5,0)
 ;;=5^Bite, Human, Contusion
 ;;^UTILITY(U,$J,358.3,12150,2)
 ;;=^28117
 ;;^UTILITY(U,$J,358.3,12151,0)
 ;;=879.8^^74^687^4
 ;;^UTILITY(U,$J,358.3,12151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12151,1,4,0)
 ;;=4^879.8
 ;;^UTILITY(U,$J,358.3,12151,1,5,0)
 ;;=5^Bite, Human, Penetrating
 ;;^UTILITY(U,$J,358.3,12151,2)
 ;;=^275021
 ;;^UTILITY(U,$J,358.3,12152,0)
 ;;=919.3^^74^687^5
 ;;^UTILITY(U,$J,358.3,12152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12152,1,4,0)
 ;;=4^919.3
 ;;^UTILITY(U,$J,358.3,12152,1,5,0)
 ;;=5^Blister, Infected
 ;;^UTILITY(U,$J,358.3,12152,2)
 ;;=^275359
 ;;^UTILITY(U,$J,358.3,12153,0)
 ;;=919.2^^74^687^6
 ;;^UTILITY(U,$J,358.3,12153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12153,1,4,0)
 ;;=4^919.2
 ;;^UTILITY(U,$J,358.3,12153,1,5,0)
 ;;=5^Blister, Not Infected
 ;;^UTILITY(U,$J,358.3,12153,2)
 ;;=^15350
 ;;^UTILITY(U,$J,358.3,12154,0)
 ;;=919.5^^74^687^7
 ;;^UTILITY(U,$J,358.3,12154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12154,1,4,0)
 ;;=4^919.5
